
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy
Weixi Jiang, Li Chen, Xun Guo, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2987-3006
Open Access | Times Cited: 38
Weixi Jiang, Li Chen, Xun Guo, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2987-3006
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum
Koyeli Girigoswami, Pragya Pallavi, Agnishwar Girigoswami
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Koyeli Girigoswami, Pragya Pallavi, Agnishwar Girigoswami
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer
Pengyu Fan, Jiajia Wang, Ruolei Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Pengyu Fan, Jiajia Wang, Ruolei Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer
Wanli Zhang, Yanxia Liao, Chengdong Liu, et al.
Disease Markers (2023) Vol. 2023, pp. 1-32
Open Access | Times Cited: 4
Wanli Zhang, Yanxia Liao, Chengdong Liu, et al.
Disease Markers (2023) Vol. 2023, pp. 1-32
Open Access | Times Cited: 4
Advanced Strategies for Strengthening the Immune Activation Effect of Traditional Antitumor Therapies
Jingyi Ning, Xinxin Lu, Jianhui Dong, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 8, pp. 4701-4715
Closed Access | Times Cited: 1
Jingyi Ning, Xinxin Lu, Jianhui Dong, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 8, pp. 4701-4715
Closed Access | Times Cited: 1
Highly Efficient Synergistic Chemotherapy and Magnetic Resonance Imaging for Targeted Ovarian Cancer Therapy Using Hyaluronic Acid‐Coated Coordination Polymer Nanoparticles
Guang Li, Shengying Shi, Jingxiu Tan, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Guang Li, Shengying Shi, Jingxiu Tan, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Nanomedicine’s Transformative Role in Advancing Cancer Treatment
Jai R. Vengurlekar, Bharti B. Bhaware, Thottethodi Subrahmanya Keshava Prasad, et al.
Nanotechnology in the life sciences (2024), pp. 59-105
Closed Access | Times Cited: 1
Jai R. Vengurlekar, Bharti B. Bhaware, Thottethodi Subrahmanya Keshava Prasad, et al.
Nanotechnology in the life sciences (2024), pp. 59-105
Closed Access | Times Cited: 1
Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy
Huamei He, Denghui Zhu, Ai-Qing Ma, et al.
Small Structures (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 2
Huamei He, Denghui Zhu, Ai-Qing Ma, et al.
Small Structures (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 2
DERL2 (derlin 2) stabilizes BAG6 (BAG cochaperone 6) in chemotherapy resistance of cholangiocarcinoma
Luzheng Liu, Jincai Wu, Yanggang Yan, et al.
Journal of Physiology and Biochemistry (2023) Vol. 80, Iss. 1, pp. 81-97
Open Access | Times Cited: 2
Luzheng Liu, Jincai Wu, Yanggang Yan, et al.
Journal of Physiology and Biochemistry (2023) Vol. 80, Iss. 1, pp. 81-97
Open Access | Times Cited: 2
A novel signature integrated endoplasmic reticulum stress and apoptosis related genes to predict prognosis for breast cancer
Hao Fan, Mingjie Dong, Chaomin Ren, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28279-e28279
Open Access
Hao Fan, Mingjie Dong, Chaomin Ren, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28279-e28279
Open Access
Biogenic Ag-doped ZnO nanostructures induced cytotoxicity in luminal A and triple-negative human breast cancer cells
Poonam Banthia, Rishi Vyas, Ankur Jain, et al.
Nanomedicine (2024) Vol. 19, Iss. 29, pp. 2479-2493
Closed Access
Poonam Banthia, Rishi Vyas, Ankur Jain, et al.
Nanomedicine (2024) Vol. 19, Iss. 29, pp. 2479-2493
Closed Access
Navigating heme pathways: the breach of heme oxygenase and hemin in breast cancer
Valeria Consoli, Valeria Sorrenti, Maria Gulisano, et al.
Molecular and Cellular Biochemistry (2024)
Open Access
Valeria Consoli, Valeria Sorrenti, Maria Gulisano, et al.
Molecular and Cellular Biochemistry (2024)
Open Access
PFOS and Its Commercial Alternative, 6:2 Cl-PFESA, Induce Multidrug Resistance in Pancreatic Cancer
Jiawei Hong, Keyi Du, Weichen Zhang, et al.
Environmental Science & Technology (2024)
Closed Access
Jiawei Hong, Keyi Du, Weichen Zhang, et al.
Environmental Science & Technology (2024)
Closed Access
Research progress on the beneficial effects of exercise on endocrine system-related diseases in women by regulating ER stress pathways
Dejian Chen, Shuo Zhang, Shuhao Sheng, et al.
Research Square (Research Square) (2023)
Open Access
Dejian Chen, Shuo Zhang, Shuhao Sheng, et al.
Research Square (Research Square) (2023)
Open Access